MX9700379A - Acido(-)-(3r)-3-metil-4-(4-(4-(4-piridil)piperazin-1-il)-fenoxi)butirico como inhibidor de la adhesion celular. - Google Patents

Acido(-)-(3r)-3-metil-4-(4-(4-(4-piridil)piperazin-1-il)-fenoxi)butirico como inhibidor de la adhesion celular.

Info

Publication number
MX9700379A
MX9700379A MX9700379A MX9700379A MX9700379A MX 9700379 A MX9700379 A MX 9700379A MX 9700379 A MX9700379 A MX 9700379A MX 9700379 A MX9700379 A MX 9700379A MX 9700379 A MX9700379 A MX 9700379A
Authority
MX
Mexico
Prior art keywords
piperazin
phenoxy
pyridyl
methyl
butyric acid
Prior art date
Application number
MX9700379A
Other languages
English (en)
Inventor
Stuart Dennett Mills
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/457,538 external-priority patent/US5652242A/en
Priority claimed from GBGB9518188.9A external-priority patent/GB9518188D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of MX9700379A publication Critical patent/MX9700379A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se describe un nuevo compuesto opticamente activo de ácido (-)-(3R)-3-metil-4-{4-[4-4-piridil)-piperazil-1-il ]fenxoxi)butírico y sales, ésteres, amidas o solvatos farmacéuticamente aceptables del mismo. Procesos para la preparacion del compuesto, composiciones farmacéuticas que contienen el compuesto y su uso para inhibir la adhesion celular, por ejemplo la agregacion de plaquetas.
MX9700379A 1995-06-01 1996-05-28 Acido(-)-(3r)-3-metil-4-(4-(4-(4-piridil)piperazin-1-il)-fenoxi)butirico como inhibidor de la adhesion celular. MX9700379A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/457,538 US5652242A (en) 1993-03-29 1995-06-01 Heterocyclic derivatives
GBGB9518188.9A GB9518188D0 (en) 1995-09-07 1995-09-07 Optically active derivative
PCT/GB1996/001260 WO1996038416A1 (en) 1995-06-01 1996-05-28 (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy} butyric acid as cellular adhesion inhibitor

Publications (1)

Publication Number Publication Date
MX9700379A true MX9700379A (es) 1997-04-30

Family

ID=26307696

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9700379A MX9700379A (es) 1995-06-01 1996-05-28 Acido(-)-(3r)-3-metil-4-(4-(4-(4-piridil)piperazin-1-il)-fenoxi)butirico como inhibidor de la adhesion celular.

Country Status (31)

Country Link
EP (1) EP0796247A1 (es)
JP (1) JP2885941B2 (es)
KR (1) KR100245957B1 (es)
AT (1) AT406675B (es)
AU (1) AU710105B2 (es)
BE (1) BE1009520A5 (es)
BR (1) BR9606409A (es)
CA (1) CA2194397A1 (es)
CH (1) CH691808A5 (es)
CZ (1) CZ26997A3 (es)
DE (1) DE19680509T1 (es)
DK (1) DK10697A (es)
ES (1) ES2137886B1 (es)
FI (1) FI970393A (es)
GB (1) GB2304340B (es)
GR (1) GR1002702B (es)
HU (1) HUP9700274A3 (es)
IE (1) IE960405A1 (es)
IL (1) IL118477A0 (es)
IT (1) IT1290839B1 (es)
LU (1) LU90008B1 (es)
MC (1) MC2418A1 (es)
MX (1) MX9700379A (es)
NL (1) NL1003243C2 (es)
NO (1) NO307460B1 (es)
NZ (1) NZ308597A (es)
PL (1) PL318440A1 (es)
SE (1) SE510812C2 (es)
SK (1) SK13097A3 (es)
TR (1) TR199700020T1 (es)
WO (1) WO1996038416A1 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100158A3 (en) * 1982-07-28 1985-03-27 The Upjohn Company (3-pyridinyl)heteroalkarylalkanols, alkanoic acids and esters
GB8609630D0 (en) * 1986-04-19 1986-05-21 Pfizer Ltd Anti-arrhythmia agents
DE69411900T2 (de) * 1993-03-29 1998-12-10 Zeneca Ltd., London Heterozyklische derivate als plätchenaggregationsinhibitoren
ZW4194A1 (en) * 1993-03-29 1994-12-21 Zeneca Ltd Heterocyclic compounds

Also Published As

Publication number Publication date
MC2418A1 (fr) 1997-05-23
NO970437D0 (no) 1997-01-31
FI970393A0 (fi) 1997-01-30
BR9606409A (pt) 1997-09-30
TR199700020T1 (tr) 1997-04-22
HUP9700274A3 (en) 2000-02-28
NO307460B1 (no) 2000-04-10
HU9700274D0 (en) 1997-04-28
GR1002702B (el) 1997-05-22
FI970393A (fi) 1997-01-30
ITMI961113A0 (it) 1996-05-31
DE19680509T1 (de) 1997-12-04
NO970437L (no) 1997-02-20
LU90008B1 (fr) 1997-04-16
JP2885941B2 (ja) 1999-04-26
ES2137886B1 (es) 2000-08-16
AU5827296A (en) 1996-12-18
AU710105B2 (en) 1999-09-16
ATA900596A (de) 1999-12-15
CH691808A5 (de) 2001-10-31
SE9700203D0 (sv) 1997-01-24
NZ308597A (en) 1998-11-25
SE9700203L (sv) 1997-01-24
SK13097A3 (en) 1997-08-06
ITMI961113A1 (it) 1997-12-01
PL318440A1 (en) 1997-06-09
GB2304340A (en) 1997-03-19
KR100245957B1 (ko) 2000-04-01
WO1996038416A1 (en) 1996-12-05
HUP9700274A2 (hu) 1999-06-28
IE960405A1 (en) 1996-12-11
GB9627127D0 (en) 1997-02-19
IL118477A0 (en) 1996-09-12
CZ26997A3 (en) 1997-08-13
GB2304340B (en) 1998-07-29
JPH09512836A (ja) 1997-12-22
SE510812C2 (sv) 1999-06-28
BE1009520A5 (fr) 1997-04-01
EP0796247A1 (en) 1997-09-24
NL1003243C2 (nl) 1996-12-04
KR970704689A (ko) 1997-09-06
DK10697A (da) 1997-04-01
ES2137886A1 (es) 1999-12-16
CA2194397A1 (en) 1996-12-05
IT1290839B1 (it) 1998-12-14
AT406675B (de) 2000-07-25

Similar Documents

Publication Publication Date Title
ES8705387A1 (es) Un procedimiento para preparar derivados de n-aril-n-(4-piperidinil)-alcoxialquilamida
MY114388A (en) Multiple unit pharmaceutical preparation
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
DK0705254T3 (da) Phenylheterocykliske forbindelser som cyclooxygenase-2-inhibitorer
UA37181C2 (uk) ГІДРОХЛОРИД 7-<font face="Symbol">b</font>-[(Z)-2-(2-АМІНО-4-ТІАЗОЛІЛ)-3-ГІДРОКСИІМІНОАЦЕТА- МІДО]-3-(1,2,3-ТРИАЗОЛ-4-ІЛ)ТІОМЕТИЛТІО-3-ЦЕФЕМ-4-КАРБОНОВОЇ КИСЛОТИ АБО ЙОГО ГІДРАТИ, ЩО МАЮТЬ АНТИБАКТЕРІАЛЬНУ ДІЮ, ФАРМАЦЕВТИЧНА АНТИБАКТЕРІАЛЬНА КОМПОЗИЦІЯ, СПОСІБ ПРИГНІЧЕННЯ РОЗВИТКУ БАКТЕРІЙ, СПОСІБ ЛІКУВАННЯ БАКТЕРІАЛЬНИХ ІНФЕКЦІЙ
FI956341A (fi) Metyylifosfonihappoesteri, menetelmä sen valmistamiseksi ja sen käyttö
EP1026157A3 (en) Method for the synthesis of huperzine A and analogs thereof and compounds useful therein
BR0009244A (pt) Inibidores de metaloprotease di-hétero substituìdos
NO912888D0 (no) Fremgangsmaate for fremstilling av nye peperidylethere og -thioethere.
ES2137886A1 (es) Acido (-)-(3r)-3-metil-4-(4-(4-(4-piridil)piperazin-1-il)fenoxi) butirico como inhibidor de la adhesion celular.
IL112630A (en) Derivatives of (2-(ar)alkyldithioindane-2-carboxamido) tricyclic-oxobenzazepine and similar compouds useful as inhibitors of enkephalinase, their preparation and pharmaceutical compositions containing them
AU587873B2 (en) ((((3-pyridinyl)methylen)amino)oxy)alkanoic acids
AU7470098A (en) Antithrombotic agents
AU6599186A (en) N-(6-(4-0-hydrxyphenyl-1,3-dioxan-cis-5-yl)hexenoyl) suphonamide derivatives
AU7274198A (en) Antithrombotic agents
ES8500617A1 (es) Procedimiento para la preparacion de 1-(2, 4-diclorofenoxi)-3-(3, 4-dimetoxi-b-fenetilamino)-propanol-(2) racemico y opticamente activo
WO1991018600A1 (fr) Compositions pharmaceutiques pour le traitement de la fibrillation ventriculaire, du syndrome de menace de l'infarctus du myocarde et de l'angine de poitrine contenant le n-(benzoyl-3) (pyridil-3)-3 1h,3h-pyrrolo[1,2c] thiazolecarboxamide-7